The independent source for health policy research, polling, and news.
621-640 of 1,290 results
51视频 Health News and California Healthline staff made the rounds on national and local media in recent weeks to discuss topical stories. Here鈥檚 a collection of their appearances.
With Republicans now set to control the White House, Senate, and House of Representatives starting in January, their health agenda remains unclear. What is clear, however, is that just about anything could be on the table, from Medicare, Medicaid, and the Affordable Care Act, to drug prices and public health. Meanwhile, anti-abortion groups are preparing to fight the implementation of abortion rights ballot measures just passed by voters in seven states. Rachel Roubein of The Washington Post, Anna Edney of Bloomberg News, and Lauren Weber of The Washington Post join 51视频 Health News鈥 Julie Rovner to discuss these stories and more. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week that they think you should read, too.
As federal health scientists await a potential takeover by RFK Jr. and other medical skeptics in the second Trump administration, some are preparing r茅sum茅s or retirement papers.
The new Trump administration is likely to reduce subsidies for Affordable Care Act insurance plans and roll back Medicaid coverage. Public health authorities worry that anti-vaccine activist Robert F. Kennedy Jr. will be empowered.
Democrats and conservatives are divided over whether the federal health program for people over 65 should be run almost entirely by the private sector. If Trump retakes the White House, the shift to Medicare Advantage may accelerate.
Though the former president has repeatedly hyped the impact of his experimental drug program, there鈥檚 no basis for his claims in government data, and medical experts say he鈥檚 exaggerating.
Laborers have suffered in extreme heat triggered by climate change. Deaths aren鈥檛 inevitable, researchers say: Employers can save lives by providing ample water and breaks.
The outcome of the upcoming presidential election could affect the number of insured Americans, the fate of premium-reducing subsidies, the shape of Medicaid, and the cost of coverage for tens of millions of people.
The Biden administration has taken significant steps to address a problem that burdens 100 million people in America, but gains would be jeopardized by a Trump win, advocates say.
A 51视频 survey found significant shifts among women voters since late spring 鈥 all in favor of Vice President Kamala Harris.
The 2024 presidential race is taking on a familiar tone 鈥 with Democrats accusing Republicans of wanting to ban abortion and repeal the Affordable Care Act and Republicans insisting they have no such plans. Voters will determine whom they believe. Meanwhile, for the second time in a month, a state judge overturned an abortion ban, but few expect the decision to settle the matter. Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Anna Edney of Bloomberg News join 51视频 Health News chief Washington correspondent Julie Rovner to discuss these stories and more. Also this week, Rovner interviews 51视频 Health News鈥 Lauren Sausser, who reported and wrote the latest 51视频 Health News-Washington Post 鈥淏ill of the Month,鈥 about a teenage athlete whose needed surgery lacked a billing code.
Former President Donald Trump has presided over a landslide shift in Republican views on vaccines, reflected in false claims by candidates in election primaries, puzzling conspiracies from prominent conservatives, and a surge in anti-vaccine policies in statehouses.
The former president instead favored a temporary model that could鈥檝e brought down prices of some prescription drugs, but it was blocked by the courts.
Minnesota led the way on insulin affordability, culminating in 2020 when Gov. Tim Walz signed a law going further to cut costs than other state laws. Now, former President Donald Trump and Vice President Kamala Harris are vying for support from people with diabetes.
During the Trump administration, enrollment in Affordable Care Act health plans fell by more than 2 million people and the number of uninsured Americans rose.
The generally combative face-off was marked by a series of false and sometimes bizarre statements from former President Donald Trump.
Vice President Kamala Harris is seen as more aggressive than former President Donald Trump in taking on pharmaceutical companies, but Trump allies say he would also make lowering drug costs a top priority.
The former president鈥檚 claim of 300,000 annual opioid deaths contradicts government statistics.
漏 2026 51视频